{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T20:51:05Z","timestamp":1725655865153},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,11,15]]},"DOI":"10.2169\/internalmedicine.0538-17","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T18:30:05Z","timestamp":1530815405000},"page":"3271-3275","source":"Crossref","is-referenced-by-count":4,"title":["Ovarian Metastases from <i>ALK<\/i>-rearranged Lung Adenocarcinoma: A Case Report and Literature Review"],"prefix":"10.2169","volume":"57","author":[{"given":"Hajime","family":"Sasano","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimasa","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Itou","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Itani","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Kondou","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Tokui","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Tanigawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Doebele RC, Lu X, Sumey C, et al. Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer 118: 4502-4511, 2012.","DOI":"10.1002\/cncr.27409"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sekine A, Kato T, Hagiwara E, et al. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. Lung Cancer 77: 64-69, 2012.","DOI":"10.1016\/j.lungcan.2011.12.017"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Togashi Y, Masago K, Kubo T, et al. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer 117: 819-825, 2011.","DOI":"10.1002\/cncr.25618"},{"key":"4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.lungcan.2013.11.022","volume":"83","author":"A Fujiwara","year":"2014","unstructured":"4. Fujiwara A, Higashiyama M, Kanou T, et al. Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement. Lung Cancer 83: 302-304, 2014.","journal-title":"Lung Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jing X, Li F, Meng X, Liu Z, Yu J, Liu B. Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: a case report and literatures review. Cancer Biol Ther 18: 279-284, 2017.","DOI":"10.1080\/15384047.2017.1310344"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lee KA, Lee JS, Min JK, Kim HJ, Kim WS, Lee KY. Bilateral ovarian metastases from ALK rearranged non-small cell lung cancer. Tuberc Respir Dis (Seoul) 77: 258-261, 2014.","DOI":"10.4046\/trd.2014.77.6.258"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mushi RT, Yang Y, Cai Q, Zhang R, Wu G, Dong X. Ovarian metastasis from non-small cell lung cancer with ALK and EGFR mutations: a report of two cases. Oncol Lett 12: 4361-4366, 2016.","DOI":"10.3892\/ol.2016.5292"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang W, Wu W, Zhang Y. Response to crizotinib in a lung adenocarcinoma patient harboring EML4-ALK translocation with adnexal metastasis: a case report. Medicine 95: e4221, 2016.","DOI":"10.1097\/MD.0000000000004221"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. West AH, Yamada SD, MacMahon H, et al. Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterus. Case Rep Clin Pathol 1: 151-154, 2014.","DOI":"10.5430\/crcp.v1n2p151"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2: 706-714, 2007.","DOI":"10.1097\/JTO.0b013e31812f3c1a"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Timmerman D, Van Calster B, Testa A, et al. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 214: 424-437, 2016.","DOI":"10.1016\/j.ajog.2016.01.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I. Clinical implications of metastases to the ovary. Gynecol Oncol 59: 124-128, 1995.","DOI":"10.1006\/gyno.1995.1278"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 30: 277-299, 2006.","DOI":"10.1097\/01.pas.0000190787.85024.cb"},{"key":"14","unstructured":"14. Irving JA, Young RH. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis. Am J Surg Pathol 29: 997-1006, 2005."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yoshida A, Tsuta K, Nakamura H, et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 35: 1226-1234, 2011.","DOI":"10.1097\/PAS.0b013e3182233e06"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566, 2007.","DOI":"10.1038\/nature05945"},{"key":"17","unstructured":"17. Midha A, Dearden S, McCormack R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res 5: 2892-2911, 2015."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takiguchi Y, Hida T, Nokihara H, et al. Updated efficacy and safety of the j-alex study comparing alectinib (ALC) with crizotinib (CRZ) in ALK-inhibitor na\u00efve ALK fusion positive non-small cell lung cancer (ALK+ NSCLC). J Clin Oncol 35: 9064, 2017.","DOI":"10.1200\/JCO.2017.35.15_suppl.9064"},{"key":"19","unstructured":"19. Shaw AT, Peters S, Mok T, et al. Alectinib versus crizotinib in treatment-naive advanced ALK-positive non-small cell lung cancer (NSCLC): primary results of the global phase III ALEX study. J Clin Oncol 35: LBA9008-LBA, 2017."},{"key":"20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(17)30565-2","volume":"390","author":"T Hida","year":"2017","unstructured":"20. Hida T, Nokihara H, Kondo M, et al. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Lancet 390: 29-39, 2017.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Seto T, Kiura K, Nishio M, et al. CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study. Lancet Oncol 14: 590-598, 2013.","DOI":"10.1016\/S1470-2045(13)70142-6"},{"key":"22","unstructured":"22. Lu LC, Shao YY, Hsu CH, et al. Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer. Anticancer Res 32: 3397-3401, 2012."},{"key":"23","unstructured":"23. Ojo J, De Silva S, Han E, et al. Krukenberg tumors from colorectal cancer: presentation, treatment and outcomes. Am Surg 77: 1381-1385, 2011."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/22\/57_0538-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T00:14:37Z","timestamp":1542413677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/22\/57_0538-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":23,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0538-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}